Hims & Hers (HIMS) Stock Drops 15% After Quarterly Loss and Sales Miss
Published on Β· Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowHims & Hers Health (HIMS) stock fell 15% in premarket trading following a disappointing first-quarter performance. The company reported revenue of $608 million, which missed analysts' expectations of $617.5 million. Additionally, Hims & Hers posted a loss per share of $0.40, compared to a profit of $0.20 in the same quarter last year. The firm also cited $33.5 million in restructuring charges due to a pivot toward branded weight-loss medications, affecting overall costs and profitability, which could impact investor confidence.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
